DIPROBASE CREAM

Active substance: PARAFFIN SOFT WHITE

View full screen / Print PDF » Download PDF ⇩

Transcript
06U210054IN R

PACKAGE LEAFLET: INFORMATION FOR THE USER

Diprobase® Cream
Read all of this leaflet carefully before you start using this medicine.
– Keep this leaflet. You may need to read it again.
– If you have any further questions, ask your doctor or pharmacist.
– This medicine has been prescribed for you. Do not pass it on to others. It may harm them, even if
their symptoms are the same as yours.
– If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please
tell your doctor or pharmacist.
In this leaflet:
1. What Diprobase is and what it is used for
2. Before you use Diprobase
3. How to use Diprobase
4. Possible side effects
5. How to store Diprobase
6. Further information
1. WHAT DIPROBASE IS AND WHAT IT IS USED FOR
Diprobase is an emollient, moisturising and protective cream. It helps to soothe, smooth and hydrate
the skin and prevent moisture loss.
In adults and children, Diprobase Cream is used to treat red, inflamed, damaged, dry or chapped skin
and to protect raw skin areas. If you are suffering from a skin condition called eczema, and your skin
is dry, the cream can be applied before having a bath, to prevent your skin from drying even further.
Eczema is a common skin disease, which causes the skin to become red and itchy.
2. BEFORE YOU USE DIPROBASE
Do not use DIPROBASE
– if you, or your child, have ever had an allergic reaction to Diprobase or any of its ingredients.
Ask your doctor or pharmacist if you are not sure.
Important information about some of the ingredients of DIPROBASE
Diprobase cream contains chlorocresol and cetostearyl alcohol which may rarely cause skin reactions
(e.g. contact dermatitis) or allergic reactions. If you are worried about this or any other effects, you
should contact your doctor or pharmacist.
3. HOW TO USE DIPROBASE
Always use Diprobase exactly as your doctor has told you. You should check with your doctor or
pharmacist if you are not sure.
For adults and children, the cream should be applied thinly to cover the affected area completely,
massaging gently and thoroughly into the skin.
If the symptoms persist or the condition worsens, stop using the cream and consult your doctor or
pharmacist.
If you forget to use DIPROBASE
If you forget to use Diprobase at the right time, use it as soon as you remember, then carry on as before.

06U210054IN.indd 1

IN31GV/R

(170 x 265 mm)

11/23/10 8:46 AM

4. POSSIBLE SIDE EFFECTS
Like all medicines, Diprobase can cause side effects, although not everybody gets them.
If your symptoms persist or the condition worsens, stop using the cream and consult your doctor or
pharmacist.
Skin reactions including itching, rash, redness, peeling, burning, pain, dryness and skin inflammation
(dermatitis) have been reported with product use.
If you are worried by this or any other effects, you should tell your doctor or pharmacist.
If any of the side effects get serious, or if you notice any side effects not listed in this leaflet, please tell
your doctor or pharmacist.
5. HOW TO STORE DIPROBASE
The cream should not be stored above 25°C.
Keep out of the reach and sight of children.
Do not use the cream after the expiry date “exp” which is stamped on the pack. This can be found on
both the carton and tube. This refers to the last date of that month.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to
dispose of medicines no longer required. These measures will help protect the environment.
6. FURTHER INFORMATION
What Diprobase contains
The ingredients are white soft paraffin, cetostearyl alcohol, liquid paraffin, macrogol cetostearyl ether,
chlorocresol, sodium dihydrogen phosphate, sodium hydroxide, phosphoric acid and purified water.
What Diprobase looks like and contents of the pack
Diprobase cream is a smooth white cream. It is available in tubes containing 15g or 50g and a pump
dispenser containing 500g . Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
The holder of the Marketing Authorisation is:
MAH (UK)
Merck Sharp & Dohme Limited,
Hertford Road, Hoddesdon, Hertfordshire, EN11 9BU, UK
MAH (Ireland)
Merck Sharp & Dohme Ireland (Human Health) Limited,
Pelham House, South County Business Park, Leopardstown, Dublin 18, Ireland.
The manufacturer is:
Schering-Plough Labo NV,
Heist-op-den-Berg, Belgium
and
Schering-Plough S.p.A
Via Fratelli Kennedy, 5
26833 Comazzo (Lodi) Italy
This leaflet was last approved in March 2011.
06U210054IN V

06U210054IN.indd 2

IN31GV/R

(170 x 265 mm)

11/23/10 8:46 AM

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide
(web2)